Senior insider sale
See Remarks at XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$655.9K
100K shares
What this filing means
HECHT BETH plans to sell 100K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $655.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001950047-26-002003
Officer· See Remarks
Since Oct 2021
100K
Shares to sell
$655.9K
Approx. market value
66.67K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/3/2024
66.67KTotal acquired66.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2024 | Restricted Stock Units N/A | 66.67K | — |
| Total | 66.67K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
16.67K
Market value
$124.1K
2/2/2026
—Completed
Units to sell
16.67K
Market value
$123.8K
1/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
66.67K
Market value
$408.0K
3/2/2026
Total
Units
100K
Value
$655.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/2/2026 | 16.67K | $124.1K | — | Completed |
1/2/2026 | 16.67K | $123.8K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 66.67K | $408.0K | NASDAQ | Planned |
| Total | 100K | $655.9K | ||